Omaxe Ltd

Omaxe Ltd

$OMAXEResidential- Commercial ProjectsNSEBSE

Omaxe Ltd (OMAXE) last traded at ₹99.7, a market capitalisation of ₹1,824 crore. Over the past 52 weeks the stock has ranged between ₹62.5 and ₹109. Omaxe Ltd last reported results for the quarter ended Jun 2026, with sales of ₹406 crore and net profit of ₹1.3 crore. Figures are as of 25 Aug 2026 and are not real time.

Omaxe Ltd share price and key metrics

Current price
₹99.7
Market cap
₹1,824 cr
Book value
₹-49.3
ROE
%
ROCE
-110%
Dividend yield
0.00%
52w high / low
109/62.5

Metrics as of 25 Aug 2026. Not real time.

Omaxe Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹406 cr, up 43.9% from ₹282 cr a year earlier. Net profit turned positive at ₹1.3 cr.

Omaxe Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales389289541282321302349406
Expenses613416647452490457550399
Operating profit-223.97-126.75-106.09-169.64-169.06-155.2-201.947.32
OPM %-57.55%-43.87%-19.60%-60.10%-52.70%-51.42%-57.94%1.80%
Other income9.1411.4511.7715.7925.5417.2127.7932.77
Interest44.6456.9551.3367.0364.6853.8669.5427.08
Depreciation7.4610.4311.67.218.268.9910.057.88
Profit before tax-266.93-182.68-157.25-228.09-216.46-200.84-253.745.13
Tax %-10.28%-17.74%-5.46%-18.55%-23.12%-23.72%-24.56%74.66%
Net profit-239.48-150.28-148.67-185.77-166.42-153.2-191.421.3
EPS (₹)-13.10-8.23-8.11-10.16-9.11-8.38-10.460.05

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Omaxe Ltd annual results

Omaxe Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4766187731,6141,5611,2531,377
Operating profit-119-47-303-343-608-696-519
OPM %-25%-8%-39%-21%-39%-56%-38%
Net profit-235-162-351-406-685-697-510
EPS (₹)-12.86-8.72-19.02-22.01-37.51-38.10-27.90

TTM is the trailing twelve months to the most recent quarter.

Omaxe Ltd growth and returns

Compounded Sales Growth
10 Years
-1%
5 Years
21%
3 Years
17%
TTM
-8%
Compounded Profit Growth
10 Years
%
5 Years
%
3 Years
-87%
TTM
30%
Stock Price CAGR
10 Years
-4%
5 Years
6%
3 Years
31%
1 Year
14%
Return on Equity
10 Years
%
5 Years
%
3 Years
%
Last Year
%

Omaxe Ltd shareholding pattern

Promoters held 74.14% at Jun 2026, broadly unchanged since Jun 2025. FIIs 5.33% and DIIs 1.40%.

Omaxe Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters74.14%74.14%74.14%74.14%74.14%74.14%74.14%74.14%
FIIs7.19%7.27%7.38%6.66%6.06%5.11%6.18%5.33%
DIIs2.29%2.29%2.29%2.26%1.56%1.56%1.56%1.40%
Public16.39%16.30%16.18%16.93%18.23%19.20%18.12%19.13%
No. of shareholders49,45048,08448,38548,59849,33148,46347,58547,595

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Omaxe Ltd corporate filings

  • Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Omaxe Ltd has released copies of newspaper advertisements as part of its routine…

    Read the full analysis
  • Intimation With Respect To Project Launch And Regulatory ApprovalCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Omaxe Ltd has issued an intimation regarding the launch of a new project and the receipt…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Omaxe Ltd has submitted a formal intimation regarding the publication of a notice in…

    Read the full analysis
  • Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On August 12, 2026Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Omaxe Limited has reported a significant operational turnaround for the quarter ended…

    Read the full analysis
  • Intimation With Respect To Project Launch And Regulatory ApprovalCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Omaxe Ltd has issued an intimation regarding a new project launch and the receipt of…

    Read the full analysis
  • Closure of Trading WindowInsider Trading / SASTlow impact
    Filing PDF

    Cruxal's analysis: Please find enclosed herewith a copy of intimation w.r.t. update on Trading Window…

    Read the full analysis
  • Omaxe Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Un-audited Financial Results (Standalone ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Omaxe Limited has formally intimated the stock exchanges regarding a Board of Directors…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Omaxe Ltd

Cruxal reads every Omaxe Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Omaxe Ltd (OMAXE) Results, Financials & Share Price | Cruxal